Six Substudies From the Semaglutide Trials: Identifying Mechanisms of Benefit and Whom to Treat

J Am Coll Cardiol. 2024 Oct 22;84(17):1663-1665. doi: 10.1016/j.jacc.2024.08.038. Epub 2024 Aug 30.

Author

Neha J Pagidipati¹

Affiliation

¹ Duke Clinical Research Institute, Durham, North Carolina, USA. Electronic address: [email protected].

PMID: 39218241
DOI: 10.1016/j.jacc.2024.08.038

No abstract available

Keywords: GLP1-receptor agonist; obesity; semaglutide.

Publication types

Editorial